US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

ホーム
投資
株式
アメリカ
NASDAQ
Elixir Pharmaceuticals (MM) (ELXR) 銘柄情報

Elixir Pharmaceuticals (MM) (ELXR)

0.00

0.00

(0.00%)

終了 6月21日 5:00AM

0.00

0.00

(0.00%)

取引時間後: -

Elixir Pharmaceuticals (MM) (ELXR) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

-

( - )

買値

-

売値

-

出来高

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

-

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 0

発行済株式数

858,198

配当利回り

PER

-

1 株当たり利益 (EPS)

-29.17

歳入

35k

純利益

-21.15M

Elixir Pharmaceuticals, Inc. went out of business. Elixir Pharmaceuticals, Inc., a pharmaceutical company, discovers, develops, and commercializes pharmaceuticals for the treatment of metabolic diseases. It develops small molecule drugs that mimic longevity responses, as well as used to treat a rang... Elixir Pharmaceuticals, Inc. went out of business. Elixir Pharmaceuticals, Inc., a pharmaceutical company, discovers, develops, and commercializes pharmaceuticals for the treatment of metabolic diseases. It develops small molecule drugs that mimic longevity responses, as well as used to treat a range of age-related diseases, including diabetes and obesity. The company’s products include Metgluna and Glinsuna for the treatment of type 2 diabetes; Ghrelin, an oral antagonist for the treatment of metabolic diseases; and EX-1314, an oral drug developed for the treatment of type 1 diabetic gastroparesis. It has strategic alliances/partnerships with Kissei Pharmaceuticals, Bristol-Myers Squibb, Siena Biotech S.p.A., and Novartis Pharmaceuticals. The company was founded in 1999 and is headquartered in Cambridge, Massachusetts. 詳細を表示

セクター

-

業界

-

本社

Cambridge, United States

設立

1999

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

ELXR - Frequently Asked Questions (FAQ)

What is the current Elixir Pharmaceuticals (MM) share price?

The current share price of Elixir Pharmaceuticals (MM) is US$ 0.00

How many Elixir Pharmaceuticals (MM) shares are in issue?

Elixir Pharmaceuticals (MM) has 858,198 shares in issue

What is the 1 year trading range for Elixir Pharmaceuticals (MM) share price?

Elixir Pharmaceuticals (MM) has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the registered address of Elixir Pharmaceuticals (MM)?

The registered address for Elixir Pharmaceuticals (MM) is 300 Putnam Avenue, Cambridge, Massachusetts, 02139

Downtownguy

Downtownguy 18分前

Agree on Royal Dornoch…if you can get there I would recommend. My fav was Kingsbarns, along with the experience of the Old Course. Castle course and views are very cool, too.

hardlesson

hardlesson 18分前

Wipe your nose pumping lie supporter. Lol

jour_trader

jour_trader 20分前

100% agree. It would take a partnership or some other external interest to move it. Nasrat’s has commented on the macro environment not being conducive. It stays in limbo until then unfortunately.

upper11

upper11 25分前

97 77 54 38 Tia

Guido2

Guido2 27分前

https://www.merriam-webster.com/dictionary/implicit

https://www.merriam-webster.com/dictionary/explicit

https://www.merriam-webster.com/dictionary/dolt

Fannie Mae and Freddie Mac MBS explicitly state that they are NOT GUARANTEED BY THE US GOVERNMENT. MBS

edzett

edzett 30分前

jour_trader, Thank you for your reply, Elite couldn't get it past the FDA, you know the story. However if a foreign pharma company comes along with an interest in M/A they might consider marketing SequestOx in their terrority. In that sense there is value there but I'm not holding my breath.

z-money

z-money 32分前

That would destry all of us bag holders !!! And we were completely innocent and hopeful all along. Dilution would kill us all.

Boat Shoes Warrior

Boat Shoes Warrior 35分前

Oh My! What about the Secret Plan?

3Angels120702

3Angels120702 36分前

What can anyone do with magic diapers? Besides Blagman put the end to the RS himself. Plainly in the PR. SMH.

along4zride

along4zride 39分前

(FNMA) (MOU) 6 points
There will be no share for share exchange in possible IPO
Conservatorship remains regardless
Possible share exchange for IPO. 1 OTC (FNMA) share for one new IPO share at existing rate . Example : IPO share $ 50 each . Common share $5 each it will take 10

Forensics888

Forensics888 47分前

Each day that ticks along, this administration is complacent in this obvious fraud. It is in black and white with the government emails back and forth to purposely prevent F&F from retaining capital and begin the 100% steal of net income via NWS.. That is NOT conservatorship - that is collusion, t

Myth

all that nonsense means one thing, I really struck a nerve !

LOL

Hoghead7

Hoghead7 50分前

$30+ easily this week. And if we have a signed DC contract, which should be coming quickly, it could be $50 within weeks.

Hoghead7

Hoghead7 52分前

73 jobs now, gotta be a contract announced no later than some time in July. Few said they were not going to get ahead of orders. Must also have confidence the can get time to power less than 2 years from signing.
https://careers.fuelcellenergy.com/search/

manibiotech

manibiotech 52分前

If they had received CHM letter and preparing for an appeal then the tone at the ASM - what was said , would have been very misleading for the investors in my opinion . So I agree chances of it are very low.

WizardSanctuary18

WizardSanctuary18 52分前

Some good learnings for me! Thanks Ernie! 🙏

Forensics888

Forensics888 1時間前

And did you read the collusion, as discussed in government emails on how to keep F&F from retaining capital and keeping them from thriving? That is not conservatorship - that is outright theft. And then 100% of net profits, NWS - were funneled from F&F to the treasury. Forgive me for not caring h

FrostyIsland3

FrostyIsland3 1時間前

I think timing can still tell us a lot about whether the MHRA issued a 2nd RFI or a CHM Letter to NWBO regarding the DCVax-L MAA. To recap, most people believe that the CHM reviewed DCVax-L for a second time at their meeting on 11/27-28/2025.

"The assessment of your response to the f

The-Shadow

The-Shadow 1時間前

https://archive.org/download/Star_Trek_-_The_Next_Generation_-_A_Final_Unity_1994_Spectrum_HoloByte_

Extracts from the 1995 Spectrum HoloByte quick-reference manuals highlight a significant milestone in mid-90s PC gaming: the commercial deployment of **SoftVideo™*

stockanalyze

stockanalyze 1時間前

what the heck mid terms have to do with it? it has been 18 years and everything is known. didn't pulte said (not sure) that everything is ready to release them when president says so?

SamuiUmi

SamuiUmi 1時間前

That's great that you have access to such great tools. Thanks for keeping us filled in all the time on what you seeing. It is much appreciated.

poguemahone

poguemahone 1時間前

It’s not just Missling—the entire company (Missling, Boenish, & BOD) are all complicit in this. The fact that only Missling has been fired tells me he was as much the “fall” guy for this shady organization.

This article paints an ugly picture of the company and its motives. Most

HyGro

HyGro 1時間前

Clearly able to process -- the issues are pretty simple -- manipulated trial, violating many FDA guidelines -- FDA won't accept it. Pretty simple logic.

stockanalyze

stockanalyze 1時間前

when president says 2 corporations that are in conservatorship has market cap of 100x (1T) than what it is now (and multiply even more by 6-14 p/e), you should see a huge uptick even on otc and robinhood. but not, instead it keeps going down. it means market is seeing mnuchin 2.0.

SSKILLZ1

SSKILLZ1 1時間前

speaking of guys who are not living up to the expectations. Freddy Peralta what was that his era is now approaching near 5 after that disaster. Than again if it is a move made by the mets GM expect terrible outcomes and you won't be disappointed. I don't think it is possible to be this bad at your j

International bond 2.375...

Newcrest Mining

XPlore Resources

Bmo Canadian Stock Selec...

American Oncology Network

BMO Global Agriculture ETF

International bond 1.375...

International bond 5.75%...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。